The EMEA has recommended the suspension of marketing authorisations for all carisoprodol-containing products
- 10 Downloads
KeywordsPublic Health Marketing Withdrawal Symptom Marketing Authorisation CHMP
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.EMEA.European Medicines Agency recommends suspension of marketing authorisations for carisoprodol-containing medicinal products. Media Release: 16 Nov 2007. Available from: URL: http://www.emea.europe.eu
© Adis International limited or Adis Data Information BV 2007